The Journal of Allergy and Clinical Immunology
Volume 123, Issue 2 , Pages 434-442, February 2009

Anaphylaxis fatalities and admissions in Australia

  • Woei Kang Liew, MBBS, MRCPCH, FAMS

      Affiliations

    • Department of Allergy and Immunology, Melbourne, Australia
    • Department of Paediatric Allergy, Immunology and Rheumatology, KK Women's and Children's Hospital, Singapore
  • ,
  • Elizabeth Williamson, MSc, PhD

      Affiliations

    • Clinical Epidemiology and Biostatistics Unit, Department of Pediatrics, Melbourne, Australia
    • Murdoch Children's Research Institute, Melbourne, Australia
  • ,
  • Mimi L.K. Tang, MBBS, PhD, FRACP, FRCPA

      Affiliations

    • Department of Allergy and Immunology, Melbourne, Australia
    • Murdoch Children's Research Institute, Melbourne, Australia
    • Department of Paediatrics, University of Melbourne, Melbourne, Australia
    • Corresponding Author InformationReprint requests: Mimi L. K. Tang, MBBS, PhD, FRACP, FRCPA, Department of Allergy and Immunology, Royal Children's Hospital, Flemington Rd, Parkville, Victoria 3052, Australia.

Received 28 July 2008; received in revised form 11 October 2008; accepted 29 October 2008. published online 31 December 2008.

Background

Detailed data on fatal anaphylaxis are limited, with national anaphylaxis fatality data for the United Kingdom and food-induced anaphylaxis fatality data for the United States. Time trends for anaphylaxis fatalities are not available.

Objective

We examined causes, demographics, and time trends for anaphylaxis fatalities in Australia between January 1997 and December 2005 and compared these with findings for anaphylaxis admissions.

Methods

Data on anaphylaxis deaths and hospital admissions were extracted from a national database. Death certificate codes were analyzed to determine the likely cause and associated comorbidities.

Results

There were 112 anaphylaxis fatalities in Australia over 9 years. Causes were as follows: food, 7 (6%); drugs, 22 (20%); probable drugs, 42 (38%); insect stings, 20 (18%); undetermined, 15 (13%); and other, 6 (5%). All food-induced anaphylaxis fatalities occurred between 8 and 35 years of age with female preponderance, despite the majority of food-induced anaphylaxis admissions occurring in children less than 5 years of age. Most insect sting–induced anaphylaxis deaths occurred between 35 and 84 years almost exclusively in male subjects, although bee sting–induced admissions peak between 5 and 9 years of age with a male/female ratio of 2.7. However, most drug-induced anaphylaxis deaths occurred between 55 and 85 years with equal sex distribution similar to drug-induced anaphylaxis admissions. There was no evidence of an increase in death rates for food-induced anaphylaxis, despite food-induced anaphylaxis admissions increasing approximately 350%. In contrast, drug-induced anaphylaxis deaths increased approximately 300% compared with an approximately 150% increase in drug-induced anaphylaxis admissions.

Conclusion

The demographics for anaphylaxis deaths are different to those for anaphylaxis presentations. Anaphylaxis mortality rates remain low and stable, despite increasing anaphylaxis prevalence, with the exception of drug-induced anaphylaxis deaths, which have increased.

Key words: Anaphylaxis, fatalities, admissions, prevalence, time trends, Australia

Abbreviations used: AIHW, Australian Institute of Health and Welfare, ASR, Age-standardized rate, ICD-10, International Classification of Diseases, Tenth Revision, ICD-10-AM, International Classification of Diseases, Tenth Revision, Australian Modification, ICD-9-CM, International Classification of Diseases, Ninth Revision, Clinical Modification, UK, United Kingdom, US, United States

 

 Disclosure of potential conflict of interest: The authors have declared that they have no conflict of interest.

PII: S0091-6749(08)01929-5

doi:10.1016/j.jaci.2008.10.049

The Journal of Allergy and Clinical Immunology
Volume 123, Issue 2 , Pages 434-442, February 2009